Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W DeGregorio

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Scientific Reports|May 18, 2022
Indeterminacy of cannabis impairment and ∆<sup>9</sup>-tetrahydrocannabinol (∆<sup>9</sup>-THC) levels in blood and breathGregory T Wurz, Michael W DeGregorio
International Journal of Cancer|February 11, 2014
Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosingGregory T Wurz, Michael W DeGregorio
International Journal of Cancer|March 12, 2014
Response to: "Deceptive argumentation against diagnostic microdosing of anticancer drugs" by Dirk Theile and Gerd Mikus (Letter dated February 13, 2014)Gregory T Wurz, Michael W DeGregorio
Expert Opinion on Drug Metabolism & Toxicology|May 1, 2010
Pharmacologic evaluation of ospemifeneJamie L McCall, Michael W DeGregorio
Journal of Cannabis Research|July 7, 2022
Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ<sup>8</sup>-tetrahydrocannabinol: case studiesGregory T Wurz, Edward Montoya, Michael W DeGregorio
Oncology Research|May 5, 2007
Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in miceGregory T Wurz, Cristina Marchisano-Karpman, Michael W DeGregorio
Maturitas|January 22, 2013
Ospemifene, vulvovaginal atrophy, and breast cancerGregory T Wurz, Lin H Soe, Michael W DeGregorio
Journal of AOAC International|February 27, 2024
Complexity of Translating Analytics to Recent Cannabis Use and ImpairmentMichael W DeGregorio, Chiao-Jung Kao, Gregory T Wurz
Therapeutic Advances in Medical Oncology|January 12, 2016
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialGregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio
Steroids|August 5, 2014
Ospemifene: a first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophyMichael W DeGregorio, Robert L Zerbe, Gregory T Wurz
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 18, 2022
Indeterminacy of cannabis impairment and ∆<sup>9</sup>-tetrahydrocannabinol (∆<sup>9</sup>-THC) levels in blood and breathGregory T Wurz, Michael W DeGregorio
International Journal of Cancer|February 11, 2014
Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosingGregory T Wurz, Michael W DeGregorio
International Journal of Cancer|March 12, 2014
Response to: "Deceptive argumentation against diagnostic microdosing of anticancer drugs" by Dirk Theile and Gerd Mikus (Letter dated February 13, 2014)Gregory T Wurz, Michael W DeGregorio
Expert Opinion on Drug Metabolism & Toxicology|May 1, 2010
Pharmacologic evaluation of ospemifeneJamie L McCall, Michael W DeGregorio
Journal of Cannabis Research|July 7, 2022
Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ<sup>8</sup>-tetrahydrocannabinol: case studiesGregory T Wurz, Edward Montoya, Michael W DeGregorio
Oncology Research|May 5, 2007
Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in miceGregory T Wurz, Cristina Marchisano-Karpman, Michael W DeGregorio
Maturitas|January 22, 2013
Ospemifene, vulvovaginal atrophy, and breast cancerGregory T Wurz, Lin H Soe, Michael W DeGregorio
Journal of AOAC International|February 27, 2024
Complexity of Translating Analytics to Recent Cannabis Use and ImpairmentMichael W DeGregorio, Chiao-Jung Kao, Gregory T Wurz
Therapeutic Advances in Medical Oncology|January 12, 2016
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialGregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio
Steroids|August 5, 2014
Ospemifene: a first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophyMichael W DeGregorio, Robert L Zerbe, Gregory T Wurz
Pageof 3